Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ENOV
stocks logo

ENOV

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
585.35M
+4.34%
0.813
-17.03%
581.67M
+4.09%
0.772
-4.73%
592.47M
+4.95%
0.854
+8.05%
Estimates Revision
The market is revising Upward the revenue expectations for Enovis Corporation (ENOV) for FY2025, with the revenue forecasts being adjusted by 0.11% over the past three months. During the same period, the stock price has changed by -12.98%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.11%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+1.83%
In Past 3 Month
Stock Price
Go Down
down Image
-12.98%
In Past 3 Month
Wall Street analysts forecast ENOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENOV is 49.00 USD with a low forecast of 44.00 USD and a high forecast of 58.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast ENOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENOV is 49.00 USD with a low forecast of 44.00 USD and a high forecast of 58.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 27.960
sliders
Low
44.00
Averages
49.00
High
58.00
Current: 27.960
sliders
Low
44.00
Averages
49.00
High
58.00
Baird
Outperform -> Outperform
downgrade
$50 -> $45
2025-11-07
Reason
Baird
Price Target
$50 -> $45
2025-11-07
downgrade
Outperform -> Outperform
Reason
Baird lowered the firm's price target on Enovis to $45 from $50 and keeps an Outperform rating on the shares. The firm updated its model following Q3 results with consistency improved moving into 2026.
Canaccord
Buy
downgrade
$70 -> $58
2025-08-08
Reason
Canaccord
Price Target
$70 -> $58
2025-08-08
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Enovis to $58 from $70 and keeps a Buy rating on the shares. The firm said they posted a solid Q2 beat and noted the company maintained expectations to be FCF positive for the FY25 while CEO Damien McDonald outlined a vision focused on margin expansion, cash flow improvement, and disciplined execution through the EGX operating system.
UBS
Buy
downgrade
$65 -> $57
2025-08-08
Reason
UBS
Price Target
$65 -> $57
2025-08-08
downgrade
Buy
Reason
UBS lowered the firm's price target on Enovis to $57 from $65 and keeps a Buy rating on the shares.
Jehoshaphat Research
Strong Sell
initiated
2025-07-17
Reason
Jehoshaphat Research
Price Target
2025-07-17
initiated
Strong Sell
Reason
Jehoshaphat Research announced a new short position in Enovis. In a note to investors, the firm says it believes Enovis shareholders own a growth story "that's largely a figment of accountants' imaginations." The firm is short this stock because "we think its key numbers are largely fake, its real earnings power is far lower, and because it has gotten by for many years on a plethora of accounting and language games that simply won't work if the company is too debt-laden to do more large, frequent deals." Reference Link
Canaccord
Buy
downgrade
$75 -> $70
2025-05-14
Reason
Canaccord
Price Target
$75 -> $70
2025-05-14
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Enovis to $70 from $75 and keeps a Buy rating on the shares. The firm updated its model following Q1 results and the release of its 10Q.Canaccord lowered the price target by applying the same EV/Sales multiple in their last valuation update. While the comp group valuation average is slightly higher and their 2026 revenue estimate has risen, they impose a larger discount to the comp group.
JMP
Citizens
Outperform
maintain
$62 -> $55
2025-05-09
Reason
JMP
Citizens
Price Target
$62 -> $55
2025-05-09
maintain
Outperform
Reason
Citizens JMP lowered the firm's price target on Enovis to $55 from $62 and keeps an Outperform rating on the shares. Consolidated Q1 results in sales and adjusted EBITDA nearly matched consensus, and updated guidance for 2025 reflects the positive impacts of foreign exchange on the top-line range and the negative impact of tariffs on EPS and adjusted EBITDA, the firm says. The stock's valuation does not fully capture the benefits and potential upside of the complete integration of the Lima acquisition, Citizens argues.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Enovis Corp (ENOV.N) is 8.65, compared to its 5-year average forward P/E of 20.76. For a more detailed relative valuation and DCF analysis to assess Enovis Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
20.76
Current PE
8.65
Overvalued PE
30.26
Undervalued PE
11.27

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
12.52
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
18.36
Undervalued EV/EBITDA
6.68

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.60
Current PS
0.00
Overvalued PS
2.32
Undervalued PS
0.88
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

ENOV News & Events

Events Timeline

(ET)
2025-11-06
06:09:37
Enovis increases FY25 adjusted EPS forecast to $3.10-$3.25, up from $3.05-$3.20
select
2025-11-06
06:08:34
Enovis announces Q3 adjusted EPS of 75 cents, surpassing consensus estimate of 65 cents.
select
2025-10-08 (ET)
2025-10-08
08:16:49
Enovis finalizes sale of Dr. Comfort division, generating up to $60M in revenue
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
6.0
11-08Benzinga
Wells Fargo Keeps Overweight Rating on Enovis and Increases Price Target to $42

  • Real-time Intelligence: Benzinga Pro offers traders the fastest news alerts to stay updated on market movements.

  • Exclusive Content: Subscribers gain access to unique stories and insights generated by Benzinga reporters.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, enhancing their trading strategies.

  • Market Winning Tools: The platform is designed to help traders succeed in the markets with accurate stock market intelligence.

[object Object]
Preview
3.0
10-27NASDAQ.COM
Inside Look: IJR Projected to Rise by 14%

  • ETF Analysis: The iShares Core S&P Small-Cap ETF (IJR) has an implied analyst target price of $137.58, indicating a potential upside of 13.57% from its current trading price of $121.14.

  • Notable Holdings: Key underlying holdings with significant upside potential include Enovis Corp (51.10% upside), Progress Software Corp (48.52% upside), and Pitney Bowes Inc (44.44% upside) based on their respective analyst target prices.

  • Market Sentiment: The disparity between current trading prices and analyst target prices raises questions about whether analysts are justified in their optimistic projections or if they are out of touch with recent market developments.

  • Investor Considerations: Investors are encouraged to conduct further research to assess the validity of analyst targets, as high price targets may lead to downgrades if they are based on outdated information.

[object Object]
Preview
9.5
10-25Newsfilter
Enovis to Host Webcast and Conference Call for Q3 2025 Results and Attend Upcoming Investor Conferences

  • Investor Conference Call: Enovis Corporation will host a conference call and live webcast on November 6, 2025, at 8:30 a.m. ET to discuss its third quarter 2025 financial results, with an earnings press release issued earlier that morning.

  • Upcoming Investor Conferences: CEO Damien McDonald and CFO Ben Berry will participate in fireside chats at the UBS Global Healthcare Conference on November 9 and the Jefferies London Healthcare Conference on November 18.

  • Accessing Webcasts: Investors can access the live webcasts and replays of the events through the "Investors" section of Enovis' website.

  • Company Overview: Enovis Corporation is a medical technology growth company focused on developing innovative solutions for better patient outcomes, with its shares listed on the NYSE under the symbol ENOV.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Enovis Corp (ENOV) stock price today?

The current price of ENOV is 27.96 USD — it has decreased -4.51 % in the last trading day.

arrow icon

What is Enovis Corp (ENOV)'s business?

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

arrow icon

What is the price predicton of ENOV Stock?

Wall Street analysts forecast ENOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENOV is 49.00 USD with a low forecast of 44.00 USD and a high forecast of 58.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Enovis Corp (ENOV)'s revenue for the last quarter?

Enovis Corp revenue for the last quarter amounts to 548.91M USD, increased 8.65 % YoY.

arrow icon

What is Enovis Corp (ENOV)'s earnings per share (EPS) for the last quarter?

Enovis Corp. EPS for the last quarter amounts to -9.99 USD, increased 1652.63 % YoY.

arrow icon

What changes have occurred in the market's expectations for Enovis Corp (ENOV)'s fundamentals?

The market is revising Upward the revenue expectations for Enovis Corporation (ENOV) for FY2025, with the revenue forecasts being adjusted by 0.11% over the past three months. During the same period, the stock price has changed by -12.98%.
arrow icon

How many employees does Enovis Corp (ENOV). have?

Enovis Corp (ENOV) has 7367 emplpoyees as of December 05 2025.

arrow icon

What is Enovis Corp (ENOV) market cap?

Today ENOV has the market capitalization of 1.60B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free